Curated News
By: NewsRamp Editorial Staff
August 28, 2026
SS Innovations Expands Robotic Surgery Reach with 12,000+ Procedures
TLDR
- SS Innovations' SSi Mantra has over 200 systems installed and 12,000 procedures, positioning it ahead in the global robotic surgery market.
- SS Innovations expands globally by installing SSi Mantra systems, training physicians, and seeking FDA and EU approvals for regulatory clearance.
- Affordable robotic surgery from SS Innovations increases access to minimally invasive procedures, improving patient outcomes worldwide.
- SSi Mantra supports over 170 surgical indications, including cardiac and telesurgeries, with future plans for AI and military use.
Impact - Why it Matters
The expansion of SS Innovations in robotic surgery matters because it signifies a shift towards more accessible and affordable advanced surgical technology globally. With over 12,000 procedures performed and a growing installed base, the SSi Mantra system is proving that robotic surgery can be brought to diverse healthcare settings, including cardiac and telesurgery. This not only improves patient outcomes through minimally invasive options but also addresses the critical need for surgical care in underserved regions, potentially transforming healthcare delivery and making life-saving procedures more widely available.
Summary
SS Innovations International (NASDAQ: SSII) is making significant strides in the global robotic surgery market with its proprietary SSi Mantra platform. The company has installed over 200 systems worldwide, facilitating more than 12,000 robotic procedures across 170 surgical indications, including over 650 cardiac procedures and more than 170 telesurgeries. This expansion is driven by a strategy that emphasizes technological advancement, affordability, and comprehensive physician training. SS Innovations is also pursuing regulatory approvals in the U.S. and Europe, while exploring future applications in AI, advanced imaging, and specialty-specific robotics, as well as pediatric surgery and mobile units for military and disaster response.
The company's vision is to make robotic surgery accessible to a broader population globally. Its product line includes the SSi Mantra system and the SSi Mudra surgical instruments, which are designed to support various procedures, including cardiac surgery. Headquartered in India but incorporated in the U.S., SS Innovations aims to expand its presence with cost-effective solutions. Investors can stay updated with the latest news on the company's newsroom. This article is brought to you by TechMediaWire, a communications platform that connects companies with a wide audience of investors and the public through its network and syndication services.
Source Statement
This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, SS Innovations Expands Robotic Surgery Reach with 12,000+ Procedures
